Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
For overweight or insulin-resistant patients, a lower starting dose (0.10.15 mg) may reduce transient water retention
The two primary FDA-approved injectable brands are Ozempic (for type 2 diabetes) and Wegovy (for weight management)
This means food and liquid spend more time in your stomach
The step 8 clinical trial involved 338 individuals to compare the effect of weekly subcutaneous semaglutide vs liraglutide (daily) in obese and overweight patients without type 2 diabetes
While gastrointestinal side effects like nausea and diarrhea are well-documented, some patients report flu-like symptoms during treatment
&srotate=0)
US$ 23.25
US$ 28.11
US$ 29.05
